105 related articles for article (PubMed ID: 7947275)
1. Characterization of platelet aggregation induced by human colon adenocarcinoma cells and its inhibition by snake venom peptides, trigramin and rhodostomin.
Chiang HS; Swaim MW; Huang TF
Br J Haematol; 1994 Jun; 87(2):325-31. PubMed ID: 7947275
[TBL] [Abstract][Full Text] [Related]
2. Characterization of platelet aggregation induced by human breast carcinoma and its inhibition by snake venom peptides, trigramin and rhodostomin.
Chiang HS; Swaim MW; Huang TF
Breast Cancer Res Treat; 1995 Mar; 33(3):225-35. PubMed ID: 7749150
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of platelet aggregation induced by PC-3 human prostate adenocarcinoma cells and inhibited by venom peptides, trigramin and rhodostomin.
Swaim MW; Chiang HS; Huang TF
Eur J Cancer; 1996 Apr; 32A(4):715-21. PubMed ID: 8695278
[TBL] [Abstract][Full Text] [Related]
4. The Arg-Gly-Asp-containing peptide, rhodostomin, inhibits in vitro cell adhesion to extracellular matrices and platelet aggregation caused by saos-2 human osteosarcoma cells.
Chiang HS; Yang RS; Huang TF
Br J Cancer; 1995 Feb; 71(2):265-70. PubMed ID: 7841039
[TBL] [Abstract][Full Text] [Related]
5. Triflavin, an Arg-Gly-Asp containing snake venom peptide, inhibits aggregation of human platelets induced by human hepatoma cell line.
Sheu JR; Lin CH; Chung JL; Teng CM; Huang TF
Thromb Res; 1992 Jun; 66(6):679-91. PubMed ID: 1519227
[TBL] [Abstract][Full Text] [Related]
6. Triflavin, an Arg-Gly-Asp-containing peptide, inhibits tumor cell-induced platelet aggregation.
Sheu JR; Lin CH; Peng HC; Teng CM; Huang TF
Jpn J Cancer Res; 1993 Oct; 84(10):1062-71. PubMed ID: 8226281
[TBL] [Abstract][Full Text] [Related]
7. Characterization of integrin expression and regulation on SW-480 human colon adenocarcinoma cells and the effect of rhodostomin on basal and upregulated tumor cell adhesion.
Chiang HS; Peng HC; Huang TF
Biochim Biophys Acta; 1994 Dec; 1224(3):506-16. PubMed ID: 7803510
[TBL] [Abstract][Full Text] [Related]
8. Thrombin enhances the adhesion and migration of human colon adenocarcinoma cells via increased beta 3-integrin expression on the tumour cell surface and their inhibition by the snake venom peptide, rhodostomin.
Chiang HS; Yang RS; Huang TF
Br J Cancer; 1996 Apr; 73(7):902-8. PubMed ID: 8611404
[TBL] [Abstract][Full Text] [Related]
9. Involvement of platelet membrane glycoprotein Ib and glycoprotein IIb/IIIa complex in thrombin-dependent and -independent platelet aggregations induced by tumor cells.
Kitagawa H; Yamamoto N; Yamamoto K; Tanoue K; Kosaki G; Yamazaki H
Cancer Res; 1989 Feb; 49(3):537-41. PubMed ID: 2910473
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of action of the antiplatelet peptide, arietin, from Bitis arietans venom.
Huang TF; Wang WJ; Teng CM; Ouyang C
Biochim Biophys Acta; 1991 May; 1074(1):144-50. PubMed ID: 2043664
[TBL] [Abstract][Full Text] [Related]
11. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist.
Huang TF; Liu CZ; Ouyang CH; Teng CM
Biochem Pharmacol; 1991 Aug; 42(6):1209-19. PubMed ID: 1888330
[TBL] [Abstract][Full Text] [Related]
12. Elucidation of flow-mediated tumour cell-induced platelet aggregation using an ultrasound standing wave trap.
Bazou D; Santos-Martinez MJ; Medina C; Radomski MW
Br J Pharmacol; 2011 Apr; 162(7):1577-89. PubMed ID: 21182493
[TBL] [Abstract][Full Text] [Related]
13. Protracted treatment with phorbol ester modulates J-7 human hepatoma-cell-induced aggregation and coagulation of human platelet-rich plasma.
Ko FN; Yu SM; Teng CM
Int J Cancer; 1994 Dec; 59(5):706-11. PubMed ID: 7960244
[TBL] [Abstract][Full Text] [Related]
14. Plasma-dependent and -independent mechanisms of platelet aggregation induced by human tumour cell lines.
Scarlett JD; Thurlow PJ; Connellan JM; Louis CJ
Thromb Res; 1987 Jun; 46(5):715-26. PubMed ID: 3629545
[TBL] [Abstract][Full Text] [Related]
15. FcgammaRII mediates platelet aggregation caused by disintegrins and GPIIb/IIIa monoclonal antibody, AP2.
Huang TF; Chang CH; Ho PL; Chung CH
Exp Hematol; 2008 Dec; 36(12):1704-13. PubMed ID: 18809237
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.
Jurasz P; Sawicki G; Duszyk M; Sawicka J; Miranda C; Mayers I; Radomski MW
Cancer Res; 2001 Jan; 61(1):376-82. PubMed ID: 11196190
[TBL] [Abstract][Full Text] [Related]
17. Transformed rat arterial smooth muscle cells induce platelet aggregation.
Blaes N; Covacho C
Atherosclerosis; 1994 Oct; 110(2):163-74. PubMed ID: 7848366
[TBL] [Abstract][Full Text] [Related]
18. Trigramin: primary structure and its inhibition of von Willebrand factor binding to glycoprotein IIb/IIIa complex on human platelets.
Huang TF; Holt JC; Kirby EP; Niewiarowski S
Biochemistry; 1989 Jan; 28(2):661-6. PubMed ID: 2653425
[TBL] [Abstract][Full Text] [Related]
19. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex.
Huang TF; Sheu JR; Teng CM; Chen SW; Liu CS
J Biochem; 1991 Feb; 109(2):328-34. PubMed ID: 1864844
[TBL] [Abstract][Full Text] [Related]
20. Tumor cell-induced platelet aggregation in vitro by human pancreatic cancer cell lines.
Heinmöller E; Schropp T; Kisker O; Simon B; Seitz R; Weinel RJ
Scand J Gastroenterol; 1995 Oct; 30(10):1008-16. PubMed ID: 8545606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]